Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Alice van Velzen

Fellow Pediatric Oncology, Post doc researcher
Alice van Velzen
Prevention of relapse & tumor control with new cellular therapies in AML patients after allogeneic hematopoietic cell transplantation

To monitor and define tumor-associated antigen expression and to develop TCR-engineered T cell therapy directed at these specific tumor-antigen targets for high risk AML patients to reduce relapse